Similar Articles
1601 Metabolic aspects of adult patients with nonalcoholic fatty liver disease
1602 Adjuvant sorafenib in hepatocellular carcinoma: A cautionary comment of STORM trial
1603 Interplay between microRNA-17-5p, insulin-like growth factor-II through binding protein-3 in hepatocellular carcinoma
1604 Reversal of multidrug resistance of hepatocellular carcinoma cells by metformin through inhibiting NF-κB gene transcription
1605 Metastatic recurrence to a solitary lymph node four years after hepatic lobectomy for primary hepatocellular carcinoma
1606 Road map for pain management in pancreatic cancer: A review
1607 Utility of different serum fibrosis markers in diagnosing patients with chronic pancreatitis and pancreatic adenocarcinoma
1608 Novel biomarkers of fibrosis in Crohn’s disease
1609 Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms
1610 Cancer-associated fibroblasts in hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA